IDT Biologika presents its investment plans
IDT Biologika GmbH continues to invest in order to further expand its capacities and expertise. In particular, investment will include a new deep freeze storage room, a filling system for vaccines and several specialized storage facilities. The research labs will also be enlarged. The new, state-of-the-art vaccine filling lines enable us to produce large quantities at the highest level of quality. A filling line for viral vaccines and additional freeze-drying facilities have also been planned.
Managing Director, Dr. Ralf Pfirmann, highlighted the importance of the investment plans, "Our new facilities will allow us to offer biotech products on the international markets on a broader scale and of the utmost quality."
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.